To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
2021 processes to watch: Hg, TA-backed Mitratech, New Mountain’s Zep; ERT-Bioclinica merger brings TEV to $5.9 billion
PE-backed companies Miratech and Zep gear up to weigh their options in 2021, while the recently announced marriage of Cinven's Bioclinica and ERT, backed by Astorg, Nordic and Novos, brings valulation to $5.9 billion.
